$RGBP Regen BioPharma, Inc. (RGRX) (OTCQB: RGBP) a
Post# of 42186
(Total Views: 62)
Posted On: 11/30/2018 12:31:14 PM
$RGBP Regen BioPharma, Inc. (RGRX) (OTCQB: RGBP) and (OTCQB: RGBPP), reports its researchers have determined that its lead NR2F6 small molecule agonist, RG-NAH005, is now ready for testing in animal models of inflammatory bowel disease (IBD). The Company will pursue this testing as a joint venture with Zander Therapeutics Inc. Zander Therapeutics, Inc. has been granted an exclusive license by Regen to develop and commercialize Regen's NR2F6 intellectual property for veterinary applications. https://seekingalpha.com/pr/17291756-regen-bi...ase-animal
(0)
(0)
Scroll down for more posts ▼